Optimized treatment plan for integrated traditional Chinese and western medicine intervention for HBV-related primary liver cancer in the middle and advanced stages of standard treatment of case prospective, controlled, Real-World cohort study

Not Applicable

Recruiting

• Conditions: Hepatocellular Carcinoma

• Registration Number: ITMCTR2200005552
• Lead Sponsor: The Affiliated Traditional Chinese Medicine Hospital Of Southwest Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

?Meet the diagnostic criteria of chronic hepatitis B; ?Meet the diagnostic criteria of primary liver cancer; ?Barcelona stage B-D, can accept standardized treatment procedures; ?age =18 years old, =75 years old; ?sign informed consent.

Exclusion Criteria

?Patients with severe acute and chronic diseases, including myocardial infarction, stroke, heart failure, uncontrolled diabetes and HIV, etc.; ?Co-infection with other viral hepatitis, severe alcoholic liver disease, autoimmune liver disease, severe fatty liver disease, etc. Patients with other liver diseases; ?A history of drug abuse or mental illness; ?Received other research or anti-tumor drugs in the past 4 weeks; ?Pregnant or lactating women.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression-free survival;Overall survival;Overall survival;

Secondary Outcome Measures

Name	Time	Method
iver function classification;Evaluation of solid tumors (m-recist criteria);HBV DNA;chest CT;TCM symptom score;Quality of life score;AFP;